ContractLicense Agreement • May 6th, 2015 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances)
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 24b-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
TRANSITIONAL SERVICES AND SEPARATION AGREEMENTTransitional Services and Separation Agreement • May 6th, 2015 • Bluebird Bio, Inc. • Biological products, (no disgnostic substances) • Massachusetts
This Transitional Services and Separation Agreement (the “Agreement”) is entered into by and between bluebird bio, Inc., a Delaware corporation (the “Company”) and Mitchell H. Finer, Ph.D. (“Executive”) (together the “Parties”).
